Beta-blockers: A time for reappraisal

Journal of Human Hypertension

Volumn 12, Issue 12, 1998, Pages 803-806

  Kendall, M J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Antihypertensive therapy; Beta blockers; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; SHORT SURVEY; STROKE;

EID: 0032436070     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000702     Document Type: Short Survey

References (45)

1. MacMahon SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension: a review of randomised clinical trials. Prog Cardiovasc Dis 1986; 29(Suppl 1): 99-118.
2. Collins R et al. Blood pressure, strokes and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
3. MacMahon S, Peto R, Cutler J. Blood pressure, stroke, coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
4. West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet 1996; 348: 1339-1342.
5. Hansson L et al. Benefits of intensive blood pressure lowering and acetylsalicylic acid in hypertensive patients. Lancet 1998; 351: 1755-1762.
6. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. β-Blockers and sudden cardiac death. Ann Intern Med 1995; 123: 358-367.
7. Kjekshus J et al. Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 1990; 11: 43-50.
8. Soumerai S et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115-121.
9. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 1997; 18: 560-565.
10. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-412.
11. Dahlöf B et al. Morbidity and mortality in the Swedish Trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
12. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264.
13. Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764.
14. Wikstrand J et al. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988; 259: 1976-1982.
15. Olsson G et al. Primary prevention of sudden cardiovascular death in hypertensive patients: mortality results from the MAPHY study. Am J Hyperten 1991; 4: 151-158.
16. MRC Working party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 59: 364-378.
17. Green K. British MRC trial of treatment for mild hypertension - a more favourable interpretation. Am J Hypertens 1991; 4: 723-724.
18. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145-1151.
19. Wilhelmsen L et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987; 5: 561-572.
20. Holme I. MAPHY and the two arms of HAPPHY. JAMA 1989; 262: 3272-3274.
21. Veteran Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension II. Results of patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213: 1143-1151.
22. Australian National Blood Pressure Study Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; i: 1261-1267.
23. Norwegian Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. NEJM 1981; 304: 801-807.
24. Hjalmarson A et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981; ii: 823-827.
25. Olsson G et al. Metoprolol-induced reduction in post-infarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992; 13: 28-32.
26. Beta Blocker Heart Attack Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. 1. Mortality results. JAMA 1982; 247: 1707-1713.
27. Kendall M, McMurray J. Cardiovascular disease, hypertension and angina. In: Kendall MJ, Horton RC (eds). Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. 2nd edn. Martin Dunitz: Singapore, 1998, pp 9-82.
28. Yusuf S et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371.
29. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
30. Köber L et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. NEJM 1995; 333: 1670-1676.
31. Wikstrand J, Kendall M. The role of beta-receptor blockade in preventing sudden death. Eur Heart J 1992; 13 (Suppl D): 111-120.
32. Kannel WB et al. Hypertension, antihypertensive treatment and sudden coronary death: the Framingham study. Hypertension 1988; II (Suppl II): 45-50.
33. Kennedy H et al. Beta-blocker therapy in the cardiac arrhythmia suppression trial. Am J Cardiol 1994; 74: 674-680.
34. Julian DG et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-674.
35. Cairns JA, Connolly SJ, Roberts R, Gent M, CAMIAT. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-682.
36. Kendall MJ. Clinical relevance of pharmacokinetic differences between beta-blockers. Am J Cardiol 1997; 80: 15J-19J.
37. Soriano JB, Hoes AW, Meems L, Grobbee DE. Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 1997; 39(5): 445-456.
38. Julian DG, Jackson FS, Prescott RJ, Szekely P. Controlled trial of Sotalol for one year after myocardial infarction. Lancet 1982; i: 1142-1147.
39. Landray MJ, Kendall MJ. Beta-blockers in heart failure - a cardioprotective therapy? J Clin Pharm Therap 1997; 22: 181-185.
40. Goldstein S. Clinical studies on beta-blockers and heart failure preceding the MERIT-HF Trial. Am J Cardiol 1997; 80 (9B): 50J-53J.
41. Packer M et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. NEJM 1996; 334: 1349-1355.
42. Herlitz J, Waagstein F, Eindqvist J, Swedberg K. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg metoprolol trial). Am J Cardiol 1997; 80 (9B): 40J-44J.
43. Kjekshus J. Treating the diabetic patient with coronary disease. Eur Heart J 1996; 17: 1298-1301.
44. Solomon SA et al. Beta-blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination. Br Med J 1991; 303: 1100-1104.
45. Jaatela A, Baandrup S, Houtzagers J, Westergren G. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension. J Clin Pharmacol 1990; 30 (Suppl 2): S66-S71.